Top 5 Stories of the Week

Jul 23, 2020

The following are the Top 5 stories of the week on LabPulse.com as measured by member traffic.

sup,lab,801511 sup,pth,801518 sup,poc,801516 sup,mic,801512 sup,pth,801521
Latest in Home
Fda Sign Dc Social
FDA clears BD’s new fingerstick blood collection device
December 7, 2023
Handcuffs Gavel Social
Texas lab owner pleads guilty in $1.7M Medicare fraud
December 6, 2023
Hepatitis C Virus Social
CDC awards contract to Quest Diagnostics to assess hepatitis C burden
December 7, 2023
Cardiac Heart Eeg Social
High-sensitivity assay improves diagnosis for patients with heart muscle injury in U.K. study
December 6, 2023
Related Stories
2020 04 22 18 18 5522 Coronavirus Cells Lungs 400
Home
AI boosts CT's COVID-19 diagnostic performance
2019 11 01 22 16 2253 Hahn Stephen 20191101221734
Home
Senate confirms Hahn as FDA commissioner
2019 11 01 22 16 2253 Hahn Stephen 20191101221734
Home
Hahn nominated to lead FDA as commissioner
2019 08 26 19 10 2762 Lab Blood Man 400
Home
Blood test detects concussions not visible on CT scans
More in Home
FDA clears BD’s new fingerstick blood collection device
BD (Beckton, Dickinson and Company) received 510(k) clearances from the U.S. Food and Drug Administration (FDA) for its new sample collection device system that pulls blood from a fingerstick to enable common blood tests without need for a phlebotomist.
December 7, 2023
Fda Sign Dc Social
Texas lab owner pleads guilty in $1.7M Medicare fraud
A Plano, TX, lab owner has pleaded guilty to orchestrating a scheme to obtain $1.7 million from Medicare fraudulently, announced the office of the U.S. Attorney for the Northern District of Texas in a statement.
December 6, 2023
Handcuffs Gavel Social
CDC awards contract to Quest Diagnostics to assess hepatitis C burden
Quest Diagnostics has been awarded a multiyear contract by the U.S. Centers for Disease Control and Prevention (CDC) to assess the burden of hepatitis C virus (HCV) in the U.S.
December 7, 2023
Hepatitis C Virus Social
High-sensitivity assay improves diagnosis for patients with heart muscle injury in U.K. study
A high-sensitivity blood test can improve diagnosis for 1 in 5 patients who have a heart muscle injury, according to a U.K. hospital study.
December 6, 2023
Cardiac Heart Eeg Social
Self-assembling, multicellular biobots repair damaged tissue in injury model
Self-assembling, multicellular biobots can traverse and fix damaged neural tissues in a simplified injury model, suggesting that the tiny machines could have biomedical applications.
December 7, 2023
An anthrobot is shown, depth colored, with a corona of cilia that provides locomotion for the bot.
King's College London, bit.bio collaboration launched to build multicell brain models
A collaboration has been launched in the U.K. to build multicell models of the human brain deemed vital to develop novel therapies for neuronal and psychiatric disorders.
December 5, 2023
Artificial Intelligence Brain Close Social
Imaware acquires Binx Health’s consumer-testing business
Molecular diagnostics and consumer testing company Imaware has acquired Binx Health’s at-home consumer testing business for an undisclosed sum.
December 6, 2023
Doctor Lab Test Bipoc Social
Guardant Health, Cancer Research UK partner on data and research
London-based Cancer Research UK and its innovation unit, Cancer Research Horizons, are collaborating with Guardant Health on sharing technology, data, and research insights for advancing cancer detection and treatment.
December 5, 2023
Cancer Therapy Targeted Social
Court issues injunction against Invitae, ArcherDx in Natera patent infringement suit
The U.S. District Court for the District of Delaware has issued a permanent injunction against Invitae and its subsidiary ArcherDx, ordering them to stop using products containing material patented by Natera.
December 4, 2023
Lawsuit Social
UK Biobank shares 500K WGS linked to 15 years of health data
UK Biobank has made deidentified whole genome sequencing (WGS) data on 500,000 people available, enabling researchers around the world to analyze the genomics results alongside 15 years of health data on the individuals.
December 4, 2023
Science Genome Sequence Dna Map Social
Personalis to cut workforce, forms new collaboration with Tempus
In a strategy intended to cut costs, cancer genomics company Personalis has approved a layoff of up to 65 employees, approximately 20% of the Fremont, CA-based company’s workforce.
December 4, 2023
Layoff Woman Belongings Social
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
Researchers are hailing progress toward more rapid detection of antimicrobial resistance (AMR), with a susceptibility test returning results in 30 minutes.
December 1, 2023
Antibiotic Resistant Bacteria Social
Page 1 of 101
Next Page